Taking stock of the drug industry, from the lab to the medicine chest

June 18, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Good evening. This week only, get 50% off your first year of STAT+ and enjoy unlimited access to award-winning journalism, premium data tools, discounted event tickets, and much more. Thanks for reading.

Gilead HIV protection with just two shots a year: FDA approves Gilead drug Gilead's PrEP drug lenacapavir, to marketed under the name Yeztugo, provides six months protection from HIV with a single shot. By Jason Mast and Ed Silverman STAT+ | Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access? Patient advocates continue to argue that licensing deals reached with six generic drugmakers are too restrictive. By Ed Silverman STAT+ | Vinay Prasad named chief medical and science officer at FDA Vinay Prasad is taking on top roles at the FDA, solidifying his position as a top advisor to Commissioner Marty Makary. By Lizzy Lawrence Adobe STAT+ | Scholar Rock says its drug preserved lean mass in patients taking Zepound Results in proof-of-concept trial of apitegromab come as several drugmakers are testing therapies to preserve lean mass in patients on obesity drugs. By Elaine Chen STAT+ | Psychedelics proponents hope Trump administration will foster a new era RFK Jr. and Trump allies push for psychedelics to treat PTSD and depression. FDA in position to greenlight MDMA and psilocybin for mental health treatment. By Olivia Goldhill and Meghana Keshavan STAT+ | Opinion: Deep Genomics founder: Why AI for drug discovery will far exceed current expectations The future of AI in drug discovery should be ascertained not by how well it's working on traditional biotech metrics but by how quickly the AI is improving. By Brendan Frey

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser